RadNet, Inc.

RDNT Healthcare Diagnostics & Research

RadNet, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 11.5% from fiscal 2024. In the quarter to June 2026, revenue grew 25.0%, EPS fell 47.4%, free cash flow fell 43.2% and total debt rose 21.2%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

68.53 1.88 −2.67%
Market cap
$5.5B
P/E
0.0×
Fwd P/E
279×
Dividend yield
—
F-score
3/9
Altman Z
2.04
Beneish M
−2.62
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
2.94 2.63 2.01 2.11
P/FCF ratio
573.94 119.74 70.09 148.47
P/Operating CF
109.57 63.74 54.54 50.98
P/B ratio
4.41 3.96 3.18 3.44
EV/Sales
3.09 2.79 2.30 2.38
EV/EBITDA
22.35 20.37 17.05 17.55
EV/FCF
602.78 126.94 80.41 167.21
Current Ratio
1.87 1.76 1.17 1.48
Net Debt/EBITDA
3.22 3.81 15.96 5.68
Debt/Equity
0.82 0.80 0.79 0.94
Earnings Yield
(0.22%) (0.35%) (0.32%) (0.44%)
Free Cash Flow Yield
0.17% 0.84% 1.43% 0.67%
Free Cash Flow per Share
(0.10) 0.46 0.12 0.49
Book value per Share
17.30 18.03 17.55 17.92
Free Cash Flow
(7.58) 34.35 9.32 38.28
EV/EBIT
103.57 91.75 79.45 76.33
Other line items

Show all line items

Columns are period end dates